Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Murali Krishna Cherukuri"'
Autor:
Frank J Echtenkamp, Ryo Ishida, Genesis M Rivera-Marquez, Marisa Maisiak, Oleta T Johnson, Jonathan H Shrimp, Arnav Sinha, Stephen John Ralph, Ian Nisbet, Murali Krishna Cherukuri, Jason E Gestwicki, Leonard M Neckers
Publikováno v:
PNAS Nexus
PNAS nexus, vol 2, iss 4
PNAS nexus, vol 2, iss 4
The androgen receptor is a key regulator of prostate cancer and the principal target of current prostate cancer therapies collectively termed androgen deprivation therapies. Insensitivity to these drugs is a hallmark of progression to a terminal dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c14ec7cbf7dcddfe214f2794fc2679b
https://europepmc.org/articles/PMC10118397/
https://europepmc.org/articles/PMC10118397/
Autor:
Nallathamby Devasahayam, Yu Saida, Murali Krishna Cherukuri, Shun Kishimoto, Jeffrey R. Brender
Publikováno v:
Antioxid Redox Signal
Significance: Oxygen imaging techniques, which can probe the spatiotemporal heterogeneity of tumor oxygenation, could be of significant clinical utility in radiation treatment planning and in evaluating the effectiveness of hypoxia-activated prodrugs
Publikováno v:
British Journal of Cancer
Although low risk localised prostate cancer has an excellent prognosis owing to effective treatments, such as surgery, radiation, cryosurgery and hormone therapy, metastatic prostate cancer remains incurable. Existing therapeutic regimens prolong lif
Autor:
Victor Ruiz-Rodado, Murali Krishna Cherukuri, Mark R. Gilbert, Jeffrey R. Brender, Mioara Larion
Publikováno v:
Progress in nuclear magnetic resonance spectroscopy
Despite intensive research, brain tumors are amongst the malignancies with the worst prognosis; therefore, a prompt diagnosis and thoughtful assessment of the disease is required. The resistance of brain tumors to most forms of conventional therapy h
Autor:
Alejandra Cavazos-Saldana, Wei Zhang, Orieta Celiku, Murali Krishna Cherukuri, Aiguo Li, Thais S. Sabedot, Mioara Larion, Hua Song, Sue Han, Tomohiro Seki, Dionne Davis, Jeeva Munasinghe, Jane B. Trepel, Tathiane M. Malta, Adrian Lita, Tyrone Dowdy, Victor Ruiz-Rodado, Yang Liu, Chunzhang Yang, Houtan Noushmehr, Christel Herold-Mende, Sunmin Lee, Mark R. Gilbert
Publikováno v:
Neuro Oncol
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Background Early detection of increased aggressiveness of brain tumors is a major challenge in the field of neuro-oncology because of the inability of traditional imaging to uncover it. Isocitrate dehydrogenase (IDH)-mutant gliomas represent an ideal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b9b2f75ba1c0e71b156979f302bc93
https://europepmc.org/articles/PMC7158660/
https://europepmc.org/articles/PMC7158660/
Autor:
Yvonne M. Mowery, Murali Krishna Cherukuri, Timothy W. Secomb, James B. Mitchell, Mark W. Dewhirst
Publikováno v:
The Journal of clinical investigation. 129(2)
Autor:
Tomohiro Seki, Victor Ruiz-Rodado, Tyrone Dowdy, Chunzhang Yang, Meili Zhang, Sue Han, Adrian Lita, Murali Krishna Cherukuri, Mioara Larion, Mark R. Gilbert
Publikováno v:
Cancers, Vol 12, Iss 1633, p 1633 (2020)
Cancers
Volume 12
Issue 6
Cancers
Volume 12
Issue 6
Understanding the metabolic reprogramming of aggressive brain tumors has potential applications for therapeutics as well as imaging biomarkers. However, little is known about the nutrient requirements of isocitrate dehydrogenase 1 (IDH1) mutant gliom
Autor:
Oksana Gavrilova, Tatyana N. Tarasenko, Emanuele Barca, Niraj S. Trivedi, Shingo Matsumoto, Julien S. Senac, Charles P. Venditti, Salvatore DiMauro, Peter J. McGuire, Patricia M. Zerfas, Keita Saito, Murali Krishna Cherukuri, Sean Hwang, Maxim Jestin
Publikováno v:
J Mol Med (Berl)
During infection, hepatocytes must undergo a reprioritization of metabolism, termed metabolic reprogramming. Hepatic metabolic reprogramming in response to infection begins within hours of infection, suggesting a mechanism closely linked to pathogen
Autor:
Tyrone Dowdy, Kazu Yamamoto, Keita Saito, Mark R. Gilbert, Victor Ruiz Rodado, Tomohiro Seki, Orieta Celiku, Mioara Larion, Alejandra Cavazos Saldana, Aiguo Li, Adrian Lita, Murali Krishna Cherukuri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96894404d7b8eecb96a006cf55edae0b
https://europepmc.org/articles/PMC5692799/
https://europepmc.org/articles/PMC5692799/
Autor:
Mioara Larion, Christel Herold-Mende, Houtan Noushmehr, Sunmin Lee, Orieta Celiku, Murali Krishna Cherukuri, Tomohiro Seki, Jeeva Munasinghe, Adrian Lita, Dionne Davis, Tyrone Dowdy, Aiguo Li, Tathiane M. Malta, Victor Ruiz Rodado, Mark R. Gilbert, Wei Zhang, Hua Song, Jane B. Neckers, Alejandra Cavazos Saldana
Publikováno v:
Neuro-Oncology. 20:vi41-vi42
BACKGROUND: Identification of malignant progression is a major challenge in the field of Neuro-Oncology because of inability of traditional imaging methods to distinguish pseudo-progression from true progression. IDH1-mutant gliomas represent an idea